Tevogen expands T cell therapy pipeline across viral and cancer indications

Go back to Tevogen expands T cell therapy pipeline across viral and cancer indications
(NASDAQ: TVGN) Delayed: 6.75 +0.38 (5.97%)
Previous Close $6.37    52 Week High
Open $6.23    52 Week Low
Day High $6.87    P/E N/A 
Day Low $6.23    EPS
Volume 13,042       

(NASDAQ: TVGNW) Delayed: 0.05 --0 (-0%)
Previous Close $0.05    52 Week High
Open $0.05    52 Week Low
Day High $0.05    P/E N/A 
Day Low $0.04    EPS
Volume 114,609